A doctor can now review a medical scan, a pathology slide, and a patient record with help from artificial intelligence (AI) tools that can spot patterns in large amounts of health data. The United Arab Emirates has moved this technology from research projects toward real clinical use. Hospitals, laboratories, government health agencies, and technology companies now apply AI to cancer detection, radiology, pathology, patient assessment, and early disease prediction.
The UAE also has a national policy that supports this shift. In May 2026, the UAE Cabinet approved a national policy for digital healthcare services and AI in the health sector. The policy covers digital health infrastructure, AI skills for healthcare workers, data security, ethics, and wider use of AI across the medical system.
The Cabinet also approved work on a federal law for smart health applications and AI. The planned law will address licensing, accreditation, safety, patient rights, liability, and health data rules. The policy approach follows the broader focus on consistency and technical accuracy in healthcare communication, where clear terms and verified product names matter.
Cancer care has become one of the clearest areas for AI use in the UAE. In June 2026, M42's National Reference Laboratory partnered with Qritive to introduce AI support for prostate cancer diagnosis. The system works with digital pathology and helps pathologists review prostate tissue with greater speed and consistency. Doctors still make the final clinical decision, while the AI system adds another layer of analysis.
Abu Dhabi has also taken a wider approach to early cancer detection. Abu Dhabi Biobank and M42 announced a partnership with BioTwin in June 2026 to expand virtual human twin technology. The project combines biomarkers, genomic data, clinical information, and AI. Its first major use case focuses on multi-cancer screening and early disease risk.
This approach changes the role of diagnosis. Instead of waiting for clear symptoms, health systems can examine a larger set of signals and look for early signs of disease. That model also supports more personalized care, since doctors can assess a patient's health data across a longer period.
Radiology has become another major area for AI in the UAE. A June 2026 study of 100 UAE radiologists found that 67% reported using AI daily. The research examined AI adoption, clinical effects, professional attitudes, and future uses in radiology.
AI tools can review medical images and flag areas that may need closer attention. Such systems can support work with X-rays, computed tomography scans, magnetic resonance imaging, and mammograms. The technology does not remove the need for a radiologist. Instead, it can help a specialist review large volumes of images and focus attention on findings that may require further assessment.
Cleveland Clinic Abu Dhabi also uses AI in breast cancer care. Its mammography service uses Transpara to examine digital mammograms and highlight suspicious areas for clinical review. The hospital also uses advanced imaging and adaptive radiation therapy for cancer care.
The next stage goes beyond a single scan or laboratory result. Cleveland Clinic Abu Dhabi partnered with Owkin in June 2026 to launch Aila, which the hospital describes as the world's first clinical AI scientist.
The system can connect electronic health records, physician notes, pathology reports, and medical images to support clinical analysis. The first focus area is prostate cancer, with plans for wider use across other specialties.
Emirates Health Services has also introduced Amal, an AI-powered medical assistant. Amal conducts a pre-consultation interview and creates a structured medical summary for a doctor. This gives the physician organized patient information before the clinical consultation starts.
Also Read - How to Access Health Insurance in UAE?
The UAE's health strategy now extends beyond diagnosis after symptoms appear. Abu Dhabi's Future Health initiative uses the theme ‘To Sense is to Predict’ and focuses on predictive healthcare, precision medicine, advanced diagnostics, biomarkers, continuous health data, and AI analytics.
The direction is clear: AI now has a role across several stages of healthcare, from screening and image review to pathology, clinical records, risk assessment, and early disease detection. The UAE's approach also places strong attention on regulation, patient safety, data protection, and human oversight. That balance may shape how quickly hospitals can expand AI diagnosis while keeping doctors at the center of clinical decisions.